Skip to main content
OpenTrials

Clinical trial condition

Marginal Zone Lymphoma

Explore clinical trials studying Marginal Zone Lymphoma. Study availability and eligibility vary by location and protocol.

115 public trials 42 recruiting studies
Refine in advanced search Browse all conditions

Marginal Zone Lymphoma trial results

Recruiting

Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma

NCT06006117

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • INSTITUT JULES BORDET - Service Hématologie Anderlecht, Belgium
  • UNIVERSITE CATHOLIQUE DE LOUVAIN SAINT-LUC - Service Hématologie Brussels, Belgium
  • UNIVERSITAIR ZIEKENHUIS GENT - Service Hématologie Ghent, Belgium
  • CHU UCL NAMUR - SITE GODINNE - Service Hématologie Yvoir, Belgium
View all 48 locations
View Trial Details
Recruiting

SynKIR-310 for Relapsed/Refractory B-NHL

NCT06544265

Conditions
Aggressive B-Cell Non-Hodgkin Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +54 more
Locations
  • Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute Denver, Colorado, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • The University of Kansas Cancer Center Fairway, Kansas, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
View Trial Details
Recruiting

Exploratory Study of Orelabrutinib in the Treatment of Early-stage Untreated MZL

NCT07441993

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
  • Xiangyang Central Hospital Xiangyang, Hubei, China
View all 14 locations
View Trial Details

Related conditions